Tumor-Associated Macrophage Targeting of Nanomedicines in Cancer Therapy
Pharmaceutics · 29.12.2023 · 16 (1) · 61
DOI: 10.3390/pharmaceutics16010061 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 29.12.2023. Verfasst von Xuejia Kang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL 36849, USA. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 258 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The tumor microenvironment (TME) is pivotal in tumor growth and metastasis, aligning with the “Seed and Soil” theory. Within the TME, tumor-associated macrophages (TAMs) play a central role, profoundly influencing tumor progression. Strategies targeting TAMs have surfaced as potential therapeutic avenues, encompassing interventions to block TAM recruitment, eliminate TAMs, reprogram M2 TAMs, or bolster their phagocytic capabilities via specific pathways. Nanomaterials including inorganic materials, organic materials for small molecules and large molecules stand at the forefront, presenting significant opportunities for precise targeting and modulation of TAMs to enhance therapeutic efficacy in cancer treatment. This review provides an overview of the progress in designing nanoparticles for interacting with and influencing the TAMs as a significant strategy in cancer therapy. This comprehensive review presents the role of TAMs in the TME and various targeting strategies as a promising frontier in the ever-evolving field of cancer therapy. The current trends and challenges associated with TAM-based therapy in cancer are presented.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL 36849, USA.
- Materials Research and Education Center, Materials Engineering, Department of Mechanical Engineering, Auburn University, Auburn, AL 36849, USA.
- Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Guangzhou 528400, China.
- Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
- Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA 52242, USA.
- Department of Health Outcome and Research Policy, Harrison School of Pharmacy, Auburn University, Auburn, AL 36849, USA.
ORCID-Profile: Xuejia Kang, Yongzhuo Huang, Sanika Jadhav, R Jayachandra Babu
Zitieren
APA
Kang, X., Huang, Y., Wang, H., Jadhav, S., Yue, Z., Tiwari, A. K., & Babu, R. J. (2023). Tumor-Associated Macrophage Targeting of Nanomedicines in Cancer Therapy. Pharmaceutics, 16(1), 61. https://doi.org/10.3390/pharmaceutics16010061
Vancouver
Kang X, Huang Y, Wang H, Jadhav S, Yue Z, Tiwari AK, et al. Tumor-Associated Macrophage Targeting of Nanomedicines in Cancer Therapy. Pharmaceutics. 2023;16(1):61. doi:10.3390/pharmaceutics16010061
BibTeX
@article{Kang2023,
author = {Kang, Xuejia and Huang, Yongzhuo and Wang, Huiyuan and Jadhav, Sanika and Yue, Zongliang and Tiwari, Amit K and Babu, R Jayachandra},
title = {Tumor-Associated Macrophage Targeting of Nanomedicines in Cancer Therapy},
journal = {Pharmaceutics},
year = {2023},
volume = {16},
number = {1},
pages = {61},
doi = {10.3390/pharmaceutics16010061}
}
EUVIMED